Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Wet Age-related Macular Degeneration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02540369
What this trial is testing

To Describe the Use of Intravitreal Aflibercept and to Describe Follow-up as Well as Treatment Patterns in Patients With Wet Age-related Macular Degeneration (wAMD) or Diabetic Macular Edema (DME) in Routine Clinical Practice in Canada.

Who this might be right for
Wet Macular Degeneration
Bayer 2,150
Large-scale testing (Phase 3)Active Not RecruitingNCT06556368
What this trial is testing

Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK

Who this might be right for
Wet Age-related Macular Degeneration
Kodiak Sciences Inc 675
Early research (Phase 1)Study completedNCT04782271
What this trial is testing

Safety, Tolerability and Pharmacokinetic Profile of SYL1801 Eye Drops

Who this might be right for
Safety, Tolerability and Pharmacokinetic Profile in Healthy VolunteersChoroidal Neovascularization
Sylentis, S.A. 36
Testing effectiveness (Phase 2)UnknownNCT04564937
What this trial is testing

The Study of Drug SCT510A in Patients With Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Sinocelltech Ltd. 66
Post-approval studies (Phase 4)Study completedNCT01453920
What this trial is testing

Wet AMD Recurrence Rate in Patients Stable on Three Month Ranibizumab Dosing

Who this might be right for
Age Related Macular Degeneration
University Health Network, Toronto 44
Large-scale testing (Phase 3)UnknownNCT03609307
What this trial is testing

Comparison of Treatment Response to Intravitreal Injection of Combined Propranolol and Bevacizumab Versus Bevacizumab Monotherapy in Patients With Wet Age Related Macular Degeneration :A Clinical Trial

Who this might be right for
Age Related Macular Degeneration
Shahid Beheshti University of Medical Sciences 40
Early research (Phase 1)Study completedNCT04747197
What this trial is testing

First in Human Study to Evaluate the Safety and Tolerability of EYP-1901 in Patients With Wet Age Related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
EyePoint Pharmaceuticals, Inc. 17
Testing effectiveness (Phase 2)Study completedNCT04640272
What this trial is testing

A Multi-Center, Open Label, Extension Study Assessing the Efficacy and Safety of Additional Intravitreal Injections of RBM-007 in Subjects With Wet Age-related Macular Degeneration

Who this might be right for
Exudative Age-related Macular Degeneration
Ribomic USA Inc 40
Large-scale testing (Phase 3)Active Not RecruitingNCT06856577
What this trial is testing

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)Wet AMD
Adverum Biotechnologies, Inc. 311
Testing effectiveness (Phase 2)UnknownNCT00996684
What this trial is testing

Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
University of California, Los Angeles 30
Post-approval studies (Phase 4)Looking for participantsNCT05093374
What this trial is testing

Treatment of Neovascular AMD: Artificial Intelligence in Real-world Setting

Who this might be right for
Exudative Macular Degeneration
Medical University of Vienna 290
Post-approval studies (Phase 4)Ended earlyNCT02002377
What this trial is testing

Intravitreal Aflibercept in Wet Age Related Macular Degeneration Patients With an Incomplete Response to Routine Ranibizumab Injections

Who this might be right for
Age Related Macular Degeneration
Unity Health Toronto 23
Testing effectiveness (Phase 2)Study completedNCT00775411
What this trial is testing

Safety and Efficacy of a New Therapy as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) in Subjects With Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Choroidal NeovascularizationAge-Related Maculopathy
Allergan 44
Testing effectiveness (Phase 2)Looking for participantsNCT07587515
What this trial is testing

Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular (Wet) Age-Related Macular Degeneration
Eyconis INC. 30
Large-scale testing (Phase 3)Study completedNCT00058994
What this trial is testing

An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD

Who this might be right for
Macular DegenerationMaculopathy, Age-Related
Alcon Research
Large-scale testing (Phase 3)Study completedNCT02157077
What this trial is testing

Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration

Who this might be right for
Macular DegenerationWet Macular DegenerationRetinal Degeneration+2 more
Centre Hospitalier Intercommunal Creteil 90
Post-approval studies (Phase 4)UnknownNCT01670162
What this trial is testing

On-label tReatment With Intravitreal Aflibercept injectiOn for Patients With Persistent Pigment epitheliaL Detachments in Neovascular Age Related Macular Degeneration (AMD)

Who this might be right for
Age Related Macular DegenerationPigment Epithelial Detachment
Tennessee Retina 30
Testing effectiveness (Phase 2)Study completedNCT00607750
What this trial is testing

Safety and Efficacy of ATG003 in Patients With AMD Receiving Anti-VEGF

Who this might be right for
Age-Related Macular Degeneration
CoMentis 60
Not applicableStudy completedNCT02821247
What this trial is testing

Prospective Observational Study to Assess Effectiveness of Intravitreal Aflibercept in Patients With Wet Macular Degeneration in Greece

Who this might be right for
Choroidal NeovascularizationMacular Degeneration
Bayer 119
Testing effectiveness (Phase 2)Study completedNCT05637255
What this trial is testing

A Randomized, Double Masked, Parallel Group, Dose-finding Study to Evaluate SYL1801 in Patients With Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Wet Macular DegenerationNeovascular Age-related Macular DegenerationMacular Degeneration
Sylentis, S.A. 99
Next Page